ENTITY

Novavax (NVAX US)

Analysis

Health Care • United States

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Refresh

Company Event • 01 Mar 2025 05:00 • Upcoming

Add To Calendar

Q4 2024

Company Event • 12 Nov 2024 21:30 • Latest

Q3 2024

Company Event • 09 Sep 2024 20:00 • Upcoming

Add To Calendar

Investor Presentation

Company Event • 08 Aug 2024 20:30

Q2 2024

Company Event • 06 Jun 2024 19:00 • Upcoming

Add To Calendar

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00